To optimize their effectiveness, shade cases should be printed in color. A venture capitalist must decide whether to invest in a medical technology firm that licenses intellectual property from a privately held IP holding company based on a platform technology. The pair subsequently spun off Confluent Surgical to develop some, but not all, of the IP of Incept. A licensing agreement between Incept and Confluent described the details. Venture capitalist Charles Warden of Schroder Ventures Life Sciences was determining whether to invest in a Series A funding round in Confluent.
Initially quite excited about the arrangement, Warden becomes concerned about Confluent's valuation and the way it can triumph as a business when he learns about restrictions set upon Confluent by the licensing agreement. The instance describes the business model and its approach to handling risk in early stage ventures of Incept. The case also addresses issues like options and diversification preservation in addition to the relevance of trust and long term relationships in decision making in arenas that are entrepreneurial.
PUBLICATION DATE: March 25, 2009 PRODUCT #: 809062-HCC-ENG
This is just an excerpt. This case is about INNOVATION & ENTREPRENEURSHIP
